Heron Therapeutics (HRTX) Inventory: 2016-2025
Historic Inventory for Heron Therapeutics (HRTX) over the last 10 years, with Sep 2025 value amounting to $70.0 million.
- Heron Therapeutics' Inventory rose 52.39% to $70.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.0 million, marking a year-over-year increase of 52.39%. This contributed to the annual value of $53.2 million for FY2024, which is 26.24% up from last year.
- Per Heron Therapeutics' latest filing, its Inventory stood at $70.0 million for Q3 2025, which was down 4.03% from $73.0 million recorded in Q2 2025.
- Over the past 5 years, Heron Therapeutics' Inventory peaked at $73.0 million during Q2 2025, and registered a low of $100,000 during Q1 2024.
- Moreover, its 3-year median value for Inventory was $46.0 million (2024), whereas its average is $47.5 million.
- Per our database at Business Quant, Heron Therapeutics' Inventory tumbled by 99.81% in 2024 and then surged by 56,832.00% in 2025.
- Quarterly analysis of 5 years shows Heron Therapeutics' Inventory stood at $48.4 million in 2021, then rose by 12.80% to $54.6 million in 2022, then fell by 22.84% to $42.1 million in 2023, then increased by 26.24% to $53.2 million in 2024, then soared by 52.39% to $70.0 million in 2025.
- Its Inventory was $70.0 million in Q3 2025, compared to $73.0 million in Q2 2025 and $56.9 million in Q1 2025.